​

Cannabis Use and Astrocyte Health

 

Cannabis can affect astrocytes by binding to CB1 receptors on these cells, potentially disrupting brain plasticity and development.

​

How cannabis interacts with astrocytes

​

Astrocytes are glial cells that support neurons, regulate neurotransmitter levels, and contribute to brain development and plasticity. Research has shown that CB1 cannabinoid receptors are present on astrocytes, not just neurons . These receptors help regulate how the brain adapts during critical developmental periods, especially in the visual cortex and other regions.

​

In removing CB1 receptors from astrocytes reduced the brain’s ability to adapt during early developmental “critical periods”, suggesting that cannabis-like substances can interfere with normal astrocyte-mediated plasticity. This is relevant because THC, the main psychoactive compound in cannabis, activates CB1 receptors, potentially altering astrocyte function.

​

Potential consequences

• Developmental impact: In adolescents, whose brains are still maturing, cannabis exposure may disrupt astrocyte-mediated processes that shape neural circuits, possibly contributing to long-term changes in learning, memory, and attention.

• Adult brain:   The hippocampus may take longer to recover.

• Cannabis can alter structural damage in most adults, but it can alter their signaling and functional role.                                                                                                                                                               

​

Broader Brain Effects

​

Cannabis also affects neurons, synaptic pruning, and brain structure, especially in young people. These changes can be linked to cognitive effects such as memory, attention, and executive function impairments.

​

In summary: Cannabis can influence astrocyte function via CB1 receptors, which may disrupt brain plasticity and development, particularly in youth. Direct, permanent astrocyte damage, the functional changes could have lasting implications for brain health. The risk is higher with early, heavy, or chronic use.